Загрузка...
Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
Molecular characterization is currently a key step in NSCLC therapy selection. Circulating tumor cells (CTC) are excellent candidates for downstream analysis, but technology is still lagging behind. In this work, we show that the mutational status of NSCLC can be assessed on hypermetabolic CTC, dete...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6115779/ https://ncbi.nlm.nih.gov/pubmed/30110953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10080270 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|